Welcome to LookChem.com Sign In|Join Free

CAS

  • or

852540-82-0

tert-butyl 3-(3-bromophenyl)propylcarbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

852540-82-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 852540-82-0 Structure

  • Basic information

    1. Product Name: tert-butyl 3-(3-bromophenyl)propylcarbamate
    2. Synonyms: tert-butyl 3-(3-bromophenyl)propylcarbamate
    3. CAS NO:852540-82-0
    4. Molecular Formula:
    5. Molecular Weight: 314.222
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 852540-82-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: tert-butyl 3-(3-bromophenyl)propylcarbamate(CAS DataBase Reference)
    10. NIST Chemistry Reference: tert-butyl 3-(3-bromophenyl)propylcarbamate(852540-82-0)
    11. EPA Substance Registry System: tert-butyl 3-(3-bromophenyl)propylcarbamate(852540-82-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 852540-82-0(Hazardous Substances Data)

852540-82-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 852540-82-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,5,4 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 852540-82:
(8*8)+(7*5)+(6*2)+(5*5)+(4*4)+(3*0)+(2*8)+(1*2)=170
170 % 10 = 0
So 852540-82-0 is a valid CAS Registry Number.

852540-82-0Relevant articles and documents

PYRROLE mTORC INHIBITORS AND USES THEREOF

-

Paragraph 0530, (2020/01/12)

The present invention provides compounds, compositions thereof, and methods of using the same.

PYRROLE mTORC INHIBITORS AND USES THEREOF

-

Paragraph 00297, (2018/05/27)

The present invention provides compounds, compositions thereof, and methods of using the same.

AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

-

Paragraph 1258; 1260; 1289; 1292, (2016/08/07)

Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

ANTI-MALARIAL COMPOUNDS

-

Page/Page column 117, (2010/04/03)

The present invention provides tricyclic compounds, arylamide compounds, and other compounds, and compositions comprising the same, for treating malaria, and methods of treating malaria comprising administering such compounds to an animal.

ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

-

Page/Page column 140, (2009/03/07)

Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

-

, (2008/12/08)

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Enzymatic approach to unnatural glycosides with diverse aglycon scaffolds using glycosyltransferase VinC

Minami, Atsushi,Uchida, Rei,Eguchi, Tadashi,Kakinuma, Katsumi

, p. 6148 - 6149 (2007/10/03)

Glycosyltransferase VinC was explored for a construction of glycoside libraries using dTDP-vicenisamine and structurally unrelated unnatural aglycons, and new unnatural vicenisaminides were successfully constructed. Structural elements of aglycon recognit

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 852540-82-0